Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Anesteziologiya i Re...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Послеоперационное обезболивание нефопамом и нестероидными противовоспалительными препаратами у больных, оперированных по поводу опухолей области головы и шеи

Послеоперационное обезболивание нефопамом и нестероидными противовоспалительными препаратами у больных, оперированных по поводу опухолей области головы и шеи

Abstract

Представлены 83 взрослых пациента, оперированных по поводу опухолей головы и шеи, которые условно разделены на группы умеренно(49 больных) и высокотравматичных (34 больных) вмешательств. В течение трех послеоперационных суток больным проводилось обезболивание по схеме — нефопам 20 мг в/м за 30 мин до завершения операции, далее каждые 8 ч в комбинации с НПВП: теноксикам 20 мг однократно в/м после индукции, далее 20 мг в/м каждые 24 ч (58 больных) или кетопрофен 100 мг в/в за 10 мин до завершения операции, далее 100 мг в/м каждые 8—12 ч (25 больных). Для оценки обезболивания использовали 10-балльную визуально-аналоговую шкалу. Установлено, что 7 больных 1-й и 2-й групп требовали дополнительного обезболивания в 1-е сутки (боль до 5 баллов), 4 больных 1-й группы и 7 больных 2-й группы на 2-е сутки и 3 больных 2-й группы на 3-и сутки (боль до 4 баллов). Для дополнительного обезболивания в группе умеренно травматичных вмешательств использовали парацетамол и трамадол, в группе высокотравматичных операций трамадол и промедол 1 раз в сутки. Побочные реакции выявлены у 8,4% больных, преобладали тахикардия, тошнота и потливость. На основании исследования сделан вывод о надежности и безопасности разработанной мультимодальной схемы.

Materials and Methods: 83 adult patients included in the study were divided into two groups.Patients of the group-1(n— 49) had medium level of pain after cancer head and neck surgery. Patients of the group-2 (n— 34) had severe pain. Three first postoperative days their post-operative multimodal analgesia started with tenoxycam 20 mg i.m. after induction of anesthesia, then every 24 hour (58 patients). 25 patients got ketoprofen 100 mg i.m. every 8-12 hours instead of tenoxycam. All patients had nefopam 30 mg i.m. 30 min prior the end of surgery procedure, and every 8 hours afterwards. 7 patients of the group-1 had more than 4 pain scores (day 1), 4 patients at the day 2. They received tramadol or paracetamoladditionally. 7patients (group-2) also had up to 5 pain scores on the day 1, 5 patients had 4 pain scores on the day 2, and 3 patients 4 pain scores on the day 3. All that patients received additional analgesia with tramadol or trimeperidine once a day. 8.4% of patients sufferedfrom adverse reactions (tachycardia, PONV, and sweating). Conclusion: this method of multimodal postoperative analgesia is very simple and fairly efficient.

Keywords

НЕФОПАМ, ТЕНОКСИКАМ, КЕТОПРОФЕН, МУЛЬТИМОДАЛЬНАЯ ПОСЛЕОПЕРАЦИОННАЯ АНАЛЬГЕЗИЯ, ОПУХОЛИ ГОЛОВЫ И ШЕИ

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
bronze
Related to Research communities
Cancer Research